Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Heart pump registry reveals how often doctors use balloon assist devices

NCT ID NCT02900456

Knowledge-focused Sponsor: Rennes University Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed registry study tracked 177 heart patients who received an intra-aortic balloon pump (IABP), a device that helps the heart pump blood. Researchers recorded how often the pump was used, why it was used, and patient survival rates. The goal was to gather real-world data on current IABP practices, not to test a new treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
intra-aortic balloon pump (IABP)
What this could lead to
If successful, this registry could help doctors understand when IABP use is most beneficial for heart patients.
What could go wrong
This is an observational registry, not a treatment trial. It only tracks current practices and outcomes, so it won't prove whether IABP is effective or not.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

177 people

The number who actually took part.

Started

Jan 2015

Finished

Jan 2018

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Intra-aortic Balloon Pumps in patients in cardiogenic shock (CS) or at high risk situation as mechanical complications stemming from myocardial infarction (MI), critical coronary stenosis, high-risk PCI, etc

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Males and females at least of 18 of age; * Undergoing IABP treatment ; * Subject, relatives or legal guardian signified their non-opposition to participate in the study Exclusion Criteria: \- IABP insertion in immediate post-intervention period

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Interventional cardiology are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Interventional cardiology

Contacts and locations

Locations

  • CH Bretagne Atlantique

    Vannes, France

  • CH Bretagne Sud

    Lorient, France

  • CH Chartres

    Chartres, France

  • CH Intercommunal de Cornouaille

    Quimper, France

  • CH Laval

    Laval, France

  • CH Le Mans

    Le Mans, France

  • CH Saint-Brieuc

    Saint-Brieuc, France

  • CH Saint-Nazaire

    Saint-Nazaire, France

  • CHU Angers

    Angers, France

  • CHU Brest

    Brest, France

  • CHU Caen

    Caen, France

  • CHU Nantes

    Nantes, France

  • CHU Rennes

    Rennes, France

  • CHU Rouen

    Rouen, France

  • CHU Tours

    Tours, France

  • Clinique Saint Gatien

    Tours, France

  • Clinique Saint Joseph

    Angers, France

  • Clinique Saint-Hilaire

    Rouen, France

  • Communauté Hospitalière de Territoire Rance Emeraude

    St-Malo, France

  • Groupement Coopération Sanitaire Pui Cite Sanitaire

    Saint-Nazaire, France

  • Hôpital Prive Saint Martin

    Caen, France

  • Hôpital privé Beauregard

    Rennes, France

  • Nouvelles Cliniques Nantaises

    Nantes, France

  • Polyclinique Les Fleurs

    Toulon, France

  • Polyclinique Saint-Laurent

    Rennes, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.